| Age (year) |
56.50±8.91 |
56 |
29-76 |
53.86±9.73 |
54 |
25-78 |
0,149 |
| Body Mass Index (kg/m²) |
30.55±3.80 |
30 |
21-38 |
28.37±3.93 |
28 |
20-38 |
0,006 |
| RA disease duration (year) |
12.12±8.62 |
10 |
0,8-30 |
9.96±7.91 |
7 |
0,8-30 |
0,178 |
| Duration of biologic agents usage (year) |
3.38±2.23 |
3 |
0,5-10 |
2.71±1.69 |
3 |
0,5-8 |
0,156 |
| Pain Visual Analog Scale (0-100 mm) |
56.17±21.32 |
50 |
10-90 |
43.60±22.59 |
40 |
10-90 |
0,005 |
| Patient Global Assessment (0-100 mm) |
52.94±19.15 |
50 |
10-90 |
40.05±20.38 |
40 |
10-90 |
0,001 |
| HAQ score (0-3) |
0.88± 0.65 |
0,77 |
0-2,25 |
0.46±0.62 |
0,15 |
0-2,40 |
0,001 |
| Disease Activity Score in 28 joints |
3.94±1.46 |
3,7 |
1.8-7.5 |
3.47±1.23 |
3,26 |
1.2-7.2 |
0,094 |
| FES-I score (0-64) |
28.00±7.54 |
26 |
16-45 |
21.45±7.38 |
19 |
1-30 |
<0.001 |
| One Leg Stand Test (seconds) |
9.92±10.56 |
5 |
1-30 |
22.64±10.58 |
30 |
1-30 |
0,015 |
| Berg Balance Scale score (0-56) |
43.97±8.22 |
43 |
29-56 |
50.38±8.50 |
55 |
8-56 |
<0.001 |
| 10-Meter Walk Test (seconds) |
9.29±5.23 |
8 |
5-30 |
7.06±2.57 |
6,5 |
4-20 |
0,002 |
| Beck Anxiety Index score (0-63) |
13.23±6.06 |
12 |
3-27 |
9.08±7.45 |
8 |
0-37 |
0,001 |
| Beck Depression Index score (0-63) |
15.64±6.07 |
16 |
0-26 |
11.13±7.38 |
10 |
0-28 |
0,002 |
| ESR (0-20 mm/h) |
29.05±16.64 |
32 |
5-60 |
29.39±21.32 |
24 |
3-101 |
0,660 |
| C-reactive Protein (0-35 mg/dL) |
1.03±1.40 |
0,55 |
0.15-6.59 |
4.40±11.84 |
0,63 |
0,05-82 |
0,452 |
| SD: Standard deviation; Min: Minimum; Max: Maximum; RA: Rheumatoid arthritis; HAQ: Health Assessment Questionnaire; FES-I: Fall Efficacy Scale-International; ESR: Erythrocyte sedimentation rate; P value <0.05 significant. |
